-
EDITORIAL
Technosciences – A modern concept of the performative perception of sciences
F. Unger
-
COVER STORY
CordenPharma – The role of lipids in mRNA vaccine production
-
NEWS FROM COMPANIES
-
COLUMN: QUALITY & SUPPLY CHAIN SECURITY
Pharmaceutical remote auditing: Best practices during COVID-19 and beyond
J. Fries
-
HPAPIs
A hard business-focused approach to HPAPI projects
J. Mason-Home
-
BIOTECHNOLOGY
Measuring the economic footprint of the biotechnology industry in europe – A report by europabio and the wifor Institute (February 2021)
-
OLIGONUCLEOTIDES & PEPTIDES
Green circular economy applied to peptide synthesis
O. Al Musaimi, D. Al Shaer, B. G. De La Torre, F. Albericio
-
OLIGONUCLEOTIDES & PEPTIDES
The impact of European pharmacopeia regulations for peptides during the change of manufacturer at late phase
S. Mcintyre, C. Johnston, R. Bell, K. Kaltenberg-Ziolkowska
-
OLIGONUCLEOTIDES & PEPTIDES
CMC: Regulatory overview for Oligonucleotide drug substances
M. Lemaître
-
OLIGONUCLEOTIDES & PEPTIDES
Transforming oligonucleotide manufacturing
K. Murray, A. Livingston
-
OLIGONUCLEOTIDES & PEPTIDES
Alternative strategies which help improve sustainability and “green” peptide manufacturing
M. W. Pennington, D. Karounos, C. Bai
-
OLIGONUCLEOTIDES & PEPTIDES
Downstream Processes for Peptide Manufacturing: optimization strategy and latest technical trends
O. Ludemann-Hombourger, P. Möller, F. Kuster
-
COMPANY PROFILE
INDENA IS THE FIRST COMPANY IN ITALY AUTHORISED TO PRODUCE CBD
-
CONTRACT MANUFACTURING
Post Covid, a New Age for CDMOs? A Strategic Scenario for a Less Globalized Economy
P. J. F. Gommers, B. Comanita
-
CONTRACT MANUFACTURING
Re-shoring how much is really possible
J. Bruno
-
CONTRACT MANUFACTURING
Supply Chain Risk Management (SCRM) A Handy Tool for Measuring, Analyzing and Reducing Supply Risk
X. Jeanjean
-
Column: REGULATION
REACH regulation update: Towards a REACH new version in 2022
A. Conto
-
DIGITALIZATION
Digital Transformation Of The Production-Based Pharmaceutical Industry
D. Hutten
-
DIGITALIZATION
Covid-19 as digital accelerator in pharmaceutical supply chains
F. Hildebrand
-
VACCINES
Vaccines, a matter of risk/benefit ratio
B. Silvestrini, A. Silvestrini, M. Silvestrini
